Three Rochester-based Ortho-Clinical Diagnostics Inc. researchers are among recipients of parent company Johnson & Johnson Co.’s highest research and development award.
Scientists win national J&J award
Johnson & Johnson Co. has named three Rochester-based Ortho-Clinical Diagnostics Inc. researchers among recipients of the health care companyâ€™s highest research and development award.
Paul Contestable, principal scientist; Phil Hosimer, a research fellow; and Harold Warren, R&D director, are among eight scientists nationally named as 2007 recipients of the Johnson & Johnson Award for Research & Development.
The award recognizes their work in developing a blood test to screen for Chagasâ€™ disease, a parasite-borne infection that can cause lethal heart and lung infections and has been an increasingly worrisome contaminant of donated blood.
The locally developed screening test has detected some 260 Chagasâ€™ disease-contaminated U.S. blood donations, including 17 in New York, since its use was approved by the U.S. Food and Drug Administration, Johnson & Johnson said. The highest concentrations of contaminated blood turned up in California, Texas and Florida, the company added.
The Ortho-Clinical R&D team also was honored with a Rochester Business Journal Health Care Achievement Award for the same work in April.
(c) 2007 Rochester Business Journal. Obtain permission to
reprint this article.